Nxera Pharma Co., Ltd. (4565.T)

JPY 1056.0

(1.15%)

Annual Balance Sheets

(In JPY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 157.19 Billion 99.41 Billion 96.98 Billion 76.46 Billion 56.68 Billion 58.98 Billion
Total Current Assets 65.11 Billion 69.94 Billion 62.8 Billion 42.01 Billion 19.56 Billion 22.28 Billion
Cash And Short Term Investments 49.06 Billion 66.55 Billion 60.17 Billion 40 Billion 15.37 Billion 18.76 Billion
Cash and Cash Equivalents 49.06 Billion 66.55 Billion 60.08 Billion 40 Billion 15.37 Billion 18.76 Billion
Short Term Investments 316 Million - 86 Million - - -
Net Receivables 11.88 Billion 2.6 Billion 2.24 Billion 1.67 Billion 3.68 Billion 3.04 Billion
Inventory 2.9 Billion 32 Million -33 Million -312 Million - -
Other Current Assets 1.25 Billion 865 Million 427 Million 651 Million 499 Million 480 Million
Total Non-Current Assets 92.08 Billion 29.47 Billion 34.17 Billion 34.44 Billion 37.11 Billion 36.7 Billion
Net PPE 7.9 Billion 3.79 Billion 3.81 Billion 3.82 Billion 4.12 Billion 2.71 Billion
Good Will And Intangible Assets 76.91 Billion 23.88 Billion 24.21 Billion 25.93 Billion 27.36 Billion 28.54 Billion
Good Will 24.62 Billion 15.3 Billion 15.09 Billion 14.13 Billion 14.36 Billion 14.17 Billion
Intangible Assets 52.29 Billion 8.57 Billion 9.12 Billion 11.8 Billion 12.99 Billion 28.54 Billion
Long-Term Investments 3.26 Billion 1.73 Billion 5.95 Billion 4.68 Billion 5.59 Billion 5.15 Billion
Tax Assets 3.96 Billion 806 Million 86 Million 714 Million -5.59 Billion -
Other Non Current Assets 42 Million -742 Million 102 Million -707 Million 5.63 Billion 285 Million
Other Assets - - - - - -
Total Liabilities 90.38 Billion 41.48 Billion 39.51 Billion 24.08 Billion 11.6 Billion 17.4 Billion
Total Current Liabilities 17.18 Billion 4.09 Billion 7.19 Billion 2.98 Billion 2.3 Billion 5.44 Billion
Account Payables 112 Million 1.62 Billion 1.17 Billion 1.5 Billion 1.21 Billion 2.08 Billion
Tax Payables 378 Million 260 Million 279 Million 29 Million 162 Million 24 Million
Short Term Debt 6.77 Billion 176 Million 193 Million 170 Million 175 Million 2.99 Billion
Deferred Revenue 1.38 Billion 1.45 Billion 279 Million 29 Million 162 Million -2.05 Billion
Other Current Liabilities 8.91 Billion 838 Million 5.54 Billion 1.27 Billion 755 Million 2.43 Billion
Total Non Current Liabilities 73.2 Billion 37.38 Billion 32.32 Billion 21.09 Billion 9.29 Billion 11.95 Billion
Long-Term Debt 63.21 Billion 29.55 Billion 29.07 Billion 16.45 Billion 1.7 Billion 3.94 Billion
Deferred Revenue Non Current 3.88 Billion 4.79 Billion 384 Million 983 Million 1.48 Billion 4.18 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.61 Billion 118 Million 158 Million 1.2 Billion 4.09 Billion 1.29 Billion
Other Liabilities - - - - - -
Total Equity 66.81 Billion 57.93 Billion 57.46 Billion 52.38 Billion 45.07 Billion 41.58 Billion
Stock Holders Equity 66.81 Billion 57.93 Billion 57.46 Billion 52.38 Billion 45.07 Billion 41.57 Billion
Common Stock 46.8 Billion 41.33 Billion 41.03 Billion 40.22 Billion 37.47 Billion 36.85 Billion
Retained Earnings -16.1 Billion -8.91 Billion -9.76 Billion -10.78 Billion -12.26 Billion -13.69 Billion
Accumulated other comprehensive income 2.06 Billion -4.01 Billion -2.9 Billion -7.5 Billion -6.68 Billion -7.62 Billion
Common Stock Equity 66.81 Billion 57.93 Billion 57.46 Billion 52.38 Billion 45.07 Billion 41.57 Billion
Capital Lease Obligation 3.98 Billion 1.75 Billion 1.83 Billion 1.83 Billion 1.7 Billion 30 Million
Total Investments 3.26 Billion 1.73 Billion 6.04 Billion 4.68 Billion 5.59 Billion 5.15 Billion
Total Debt 73.97 Billion 29.73 Billion 29.27 Billion 16.62 Billion 1.87 Billion 6.96 Billion
Net Debt 24.9 Billion -36.82 Billion -30.81 Billion -23.38 Billion -13.49 Billion -11.79 Billion

Balance Sheet Charts